Web Session | Pharma in Brazil

The Brazilian pharmaceutical market is the sixth largest in the world, the value of its pharmaceutical market is about 30,670 million USD. The Health Sanitary Inspection in Brazil estimates that 5-7% of drugs are counterfeit - this means losses of about USD 500 million per year for the pharmaceutical industry there. To counteract this development, Brazil is also introducing a Track & Trace solution that is intended to create transparency across the entire pharmaceutical supply chain, from production and distributors to the dispensing of drugs in the pharmacy. The Go-live of the nationwide Track & Trace solution is scheduled for April 2022, but the pharmaceutical industry can start serialization as early as December 2020.

Pharmaceutical Marketing Authorization Holders (MAHs), Contract Manufacturers (CMOs), wholesalers and distributors operating in Brazil are facing procedural and logistical challenges in order to be able to act according to Brazilian market requirements & guidelines in the future.